AIP
BNGO icon

Ameritas Investment Partners’s Bionano Genomics BNGO Stock Holding History

Ameritas Investment Partners’s Portfolio BNGO Stock Details BNGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-37
Closed -$24.5K – 3126
2023
Q1 		$24.5K Hold
37
– – ﹤0.01% 2387
2022
Q4 		$42.3K Hold
37
– – ﹤0.01% 2174
2022
Q3 		$40K Hold
37
– – ﹤0.01% 2138
2022
Q2 		$30K Hold
37
– – ﹤0.01% 2307
2022
Q1 		$57K Hold
37
– – ﹤0.01% 1986
2021
Q4 		$66K Hold
37
– – ﹤0.01% 1948
2021
Q3 		$121K Hold
37
– – ﹤0.01% 1560
2021
Q2 		$162K Buy
+37
New +$146K 0.01% 1405

Other funds holding BNGO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $149B AUM 24.71% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Ameritas Investment Partners's BNGO Position: Q2 2023 in Review

Ameritas Investment Partners sold out of Bionano Genomics (BNGO) in Q2 2023, closing a stake of 37 shares — an estimated $24.5K sold.

Ameritas Investment Partners first reported a position in BNGO in Q2 2021 and held it in 8 quarters. The position peaked at $162K in Q2 2021. 108 funds tracked by Wall St. Rank hold BNGO as of Q2 2023.

  • Ameritas Investment Partners reported no remaining Bionano Genomics position as of Q2 2023 after selling out during the quarter.
  • Ameritas Investment Partners sold 37 Bionano Genomics shares in Q2 2023, an estimated $24.5K.
  • Ameritas Investment Partners first reported a position in Bionano Genomics in Q2 2021 and held it in 8 quarters.
  • Ameritas Investment Partners's Bionano Genomics position peaked at $162K in Q2 2021.
  • 108 funds tracked by Wall St. Rank held Bionano Genomics as of Q2 2023.

Based on Ameritas Investment Partners's 13F filing for Q2 2023, filed 11 Aug 2023.